CLASS II ONGOING Drug recall · Reported 8 Apr 2026 · FDA Enforcement Report

traMADol Hydrochloride Tablets, USP, 50 mg recalled

Amneal Pharmaceuticals is recalling traMADol Hydrochloride Tablets, USP, 50 mg, distributed nationwide in the US. The recall was initiated on 19 Mar 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: AM230987, Exp. Date 05/2026; AR232387, Exp. Date 12/2026.
Quantity recalled29,542 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0408-2026
FDA event ID
98623
Recalling firm
Amneal Pharmaceuticals, Bridgewater, NJ
Classification
Class II
Status
Ongoing
Recall initiated
19 Mar 2026
FDA classified
30 Mar 2026
Reported
8 Apr 2026
Type
Voluntary: Firm initiated
Reason category
Nitrosamine Impurity
Drug class
Pain Medication

Timeline

19 Mar 2026Recall initiated by company
30 Mar 2026Classified by FDA+11 days
8 Apr 2026Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).

Nitrosamines are impurities that can form during drug manufacturing or storage. Above the FDA acceptable intake limit, long-term exposure may raise cancer risk. The FDA advises patients to keep taking the medicine until they have a replacement.

Product as listed by the FDA

traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141, NDC 60219-2348-5.

Where it was distributed

Nationwide within the USA

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).

Which lots are affected?

Lot #: AM230987, Exp. Date 05/2026; AR232387, Exp. Date 12/2026.

Where was it sold?

Nationwide within the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 2 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Amneal Pharmaceuticals

All 25

Other Tramadol recalls

All 9